Company News

Share this article:

Sanofi-Aventis acquired Laboratorios Kendrick, a Mexican generic manufacturer. Sanofi hopes the purchase will extend its pharmaceutical portfolio in emerging markets. Laboratorios Kendric recorded sales of approximately $35 million in 2008.

 

Genzyme struck a deal with Bayer HealthCare to assume “primary responsibility” for the worldwide commercialization of Campath, a multiple sclerosis treatment. Genzyme also picked up Bayer's cancer drugs Fludara and Leukine, and will buy Bayer's Leukine manufacturing plant, near Seattle, for $75 - $100 million.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.